Therapeutic drug monitoring of nevirapine reduces pharmacokinetic variability but does not affect toxicity or virologic success in the ATHENA study [1]

Kristel M. Crommentuyn, Alwin D. Huitema, Kees Brinkman, Marchina E. Van Der Ende, Frank De Wolf, Jos H. Beijnen

Research output: Contribution to journalLetterpeer-review

16 Citations (Scopus)
Original languageEnglish
Pages (from-to)249-250
Number of pages2
JournalJournal of Acquired Immune Deficiency Syndromes
Volume39
Issue number2
Publication statusPublished - 1 Jun 2005
Externally publishedYes

Cite this